We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
AUM
$577M
AUM Growth
+$117M
Cap. Flow
+$70.8M
Cap. Flow %
12.28%
Top 10 Hldgs %
35.5%
Holding
108
New
25
Increased
54
Reduced
16
Closed
13

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$14.9M
2
BDX icon
Becton Dickinson
BDX
+$11.1M
3
DHR icon
Danaher
DHR
+$10.9M
4
IMGN
Immunogen Inc
IMGN
+$9.93M
5
PODD icon
Insulet
PODD
+$8.9M

Sector Composition

Rank Sector Weight
1 Healthcare 98.94%
2 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
101
Eli Lilly
LLY
$1.09T
-27,671
Closed -$9.5M
MDGL icon
102
Madrigal Pharmaceuticals
MDGL
$12.4B
-25,840
Closed -$6.26M
PRCT icon
103
Procept Biorobotics
PRCT
$1.22B
-67,252
Closed -$1.91M
ZBH icon
104
Zimmer Biomet
ZBH
$18.7B
-65,000
Closed -$8.4M
WHWK
105
Whitehawk Therapeutics
WHWK
$269M
-75,961
Closed -$550K
GRTS
106
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-151,921
Closed -$422K
ISEE
107
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-97,082
Closed -$2.36M
CTIC
108
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-1,753,630
Closed -$7.37M

Similar funds

Parkman Healthcare Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Parkman Healthcare Partners held 108 positions worth $577M, up 25% from $460M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners deployed $70.8M of net new capital in Q2 2023, opening 25 new positions and adding to 54 existing holdings. Its largest new stake was Cencora: 86,250 shares worth $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $10.2M trimmed.

  • Parkman Healthcare Partners's largest Q2 2023 buy was Cencora: 86,250 shares worth $16.6M.
  • Parkman Healthcare Partners added most to Becton Dickinson in Q2 2023, an estimated $11.1M increase.
  • Parkman Healthcare Partners's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $10.2M.
  • Parkman Healthcare Partners fully exited Elevance Health in Q2 2023, selling an estimated $9.95M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $577M portfolio in Q2 2023.
  • Parkman Healthcare Partners opened 25 new positions and closed 13 in Q2 2023.
  • Parkman Healthcare Partners's portfolio value rose 25% quarter-over-quarter to $577M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2023, filed 11 Aug 2023.